Immunogenicity of various variants of Ebola and Marburg virus glycoprotein genes in recombinant adenoviral vectors
INTRODUCTION. Marburg and Ebola viruses cause severe haemorrhagic fever in humans and primates. Currently, there are no licensed prophylactic vaccines that can simultaneously prevent the spread or reduce the severity of both diseases caused by these filoviruses. The development of effective prophyla...
Saved in:
| Main Authors: | T. A. Ozharovskaia, O. V. Zubkova, O. Popova, A. V. Kovyrshina, P. P. Goldovskaya, I. V. Vavilova, I. V. Dolzhikova, E. I. Ermolova, M. S. Kunda, N. N. Ryzhova, O. L. Voronina, D. N. Shcherbinin, D. V. Shcheblyakov, D. Y. Logunov, A. L. Gintsburg |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Ministry of Health of the Russian Federation. Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»
2024-10-01
|
| Series: | Биопрепараты: Профилактика, диагностика, лечение |
| Subjects: | |
| Online Access: | https://www.biopreparations.ru/jour/article/view/576 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Marburg virus disease Mayhem: A new threat emerges in Rwanda
by: Pawan Kumar, et al.
Published: (2024-12-01) -
Marburg Virus Disease: A Narrative Review
by: Arash Letafati, et al.
Published: (2025-05-01) -
Marburg haemorrhagic fever: A rare but fatal disease
by: G.A. Ogunbanjo
Published: (2005-05-01) -
Outbreak of Marburg Virus Disease, Equatorial Guinea, 2023
by: Stephanie Ngai, et al.
Published: (2025-05-01) -
Marburg virus: an emerging global threat
by: Balamurugan Shanmugaraj
Published: (2024-09-01)